colon cancer cells

Authors and Affiliations:

Rute C. Nunes, Carlos J. A. Ribeiro, Ângelo Monteiro, Cecília M. P. Rodrigues, Joana D. Amaral^*, Maria M. M. Santos^*

Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa. Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal

Abstract:

Authors and Affiliations:

Angela Paterna^a1, Sofia E. Gomes^a1, Pedro M. Borralho^a, Silva Mulhovo^b, Cecília M. P. Rodrigues^a and Maria-José U. Ferreira^a*

^a Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal

Investigators at the Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, from the research group headed by Cecília Rodrigues, discovered that restoration of two miRNAs commonly downregulated in colon tumors might constitute relevant candidates for future therapeutic intervention in combination with the monoclonal antibody cetuximab.  The research was recently published in the journal